Skip to main content Accessibility help
×
Home

The Causality of Depression in Schizophrenia

  • Joe Galdi (a1) and Steven R. Hirsch (a2)

Extract

The phenomenon of post-treatment depression in schizophrenia has become the subject of considerable controversy regarding its causality (Ananth and Chadirian, 1980; McGlashan and Carpenter, 1976a). But as the recent commentary by Hirsch (1982) emphasizes, the most controversial issue is focused on whether this depression is neuroleptic-induced. Hirsch himself refutes neuroleptic-induction on the basis of various uncontrolled data which seem ostensibly incompatible with this causality. Results indicating that pretreatment depressions appear in a high proportion of recently hospitalized schizophrenics, occur in drug-free patients, and frequently remit or decrease following neuroleptic therapy are cited as evidence contradicting neuroleptic-induction. Hirsch therefore proposes an alternative view: that this post-treatment depression is an integral, “revealed” aspect of the schizophrenia syndrome which arises from the same pathophysiological process (cf. McGlashan and Carpenter, 1976b).

Copyright

References

Hide All
Ananth, J. & Chadirian, A. M. (1980) Drug induced mood disorder. International Pharmacopsychiatry, 15, 5873.
Casey, J. F., Bennett, I. F., Lindsey, C. J. et al (1960) Drug therapy of schizophrenia: a controlled study of the relative effectiveness of chlorpromazine, promazine, phenobarbital, and placebo. Archives of General Psychiatry, 117, 9971003.
Floru, L., Heinrich, K. & Witter, F. (1975) The problem of postpsychotic schizophrenic depression and their pharmacological induction. International Pharmacopsychiatry, 10, 230–9.
Galdi, J., Rieder, R. O., Silber, D. & Bonato, R. R. (1981) Genetic factors in the response to neuroleptics in schizophrenia: a psychopharmacogenetic study. Psychological Medicine, 11, 713–28.
Herz, M. I. & Melville, C. (1980) Relapse in schizophrenia. American Journal of Psychiatry, 137, 801–5.
Hirsch, S. R. (1982) Depression “revealed” in schizophrenia. British Journal of Psychiatry, 140, 421–4.
Hogarty, G. E., Schooler, N. R., Ulrich, R. et al (1979) Fluphenazine and social therapy in the aftercare of schizophrenic patients. Archives of General Psychiatry, 36, 1283–94.
Johnson, D. A. W. (1981) Studies of depressive symptoms in schizophrenia. British Journal of Psychiatry, 139, 89101.
Knights, A. & Hirsch, S. R. (1981) “Revealed” depression and drug treatment for schizophrenia. Archives of General Psychiatry, 38, 806–11.
Mandel, M. R., Severe, J. B., Schooler, N. R. et al (1982) Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics. Archives of General Psychiatry, 39, 197203.
McGlashan, T. H. & Carpenter, W. T. (1976a) Postpsychotic depression in schizophrenia. Archives of General Psychiatry, 33, 231–9.
McGlashan, T. H. & Carpenter, W. T. (1976b) An investigation of the postpsychotic depressive syndrome. American Journal of Psychiatry, 133, 1419.
Moller, H. J. & von Zerssen, D. (1982) Depressive states occurring during the neuroleptic treatment of schizophrenia. Schizophrenia Bulletin, 8, 109–17.
Snyder, S., Greenberg, D. & Yamamura, H. I. (1974) Antischizophrenic drugs and brain cholinergic receptors. Archives of General Psychiatry, 31, 5861.
van Kammen, D. P., Alexander, P. E. & Bunney, W. E. (1980) Lithium treatment in postpsychotic depression. British Journal of Psychiatry, 136, 479–85.
Casey, J. F., Bennett, I. F., Lindley, C. J. et al (1960) Drug therapy of schizophrenia: a controlled study of the relative effectiveness of chlorpromazine, promazine, phenobarbitol and placebo. Archives of General Psychiatry, 117, 9971003.
Galdi, J., Reider, R. O., Silber, D. & Bonato, R. R. (1981) Genetic factors in the response to neuroleptics in schizophrenia: a psychopharmacogenetic study. Psychological Medicine, 11, 713–28.
Hirsch, S. R. (1982) Depression “revealed” in schizophrenia. British Journal of Psychiatry, 140, 421–4.
Johnson, D. A. W. (1981) Studies of depressive symptoms in schizophrenia. British Journal of Psychiatry, 139, 89101.
Knights, A. & Hirsch, S. R. (1981) Revealed depression and drug treatment for schizophrenia. Archives of General Psychiatry, 38, 806–11.
Moller, H. J. & von Zerssen, D. (1981) Depressive Symptomatik in Stationären Behandlungsverlauf von 280 schizophrenen Patienten. Pharmakopsychiatrie, 14, 172–9.
Moller, H. J. & von Zerssen, D. (1982) Depressive states occuring during the neuroleptic treatment of schizophrenia. Schizophrenia Bulletin, 8, 109–17.
Wing, J. K., Cooper, J. E. & Sartorius, N. (1974) The Measurement and Classification of Psychiatric Symptoms. London: Cambridge University Press.

The Causality of Depression in Schizophrenia

  • Joe Galdi (a1) and Steven R. Hirsch (a2)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed

The Causality of Depression in Schizophrenia

  • Joe Galdi (a1) and Steven R. Hirsch (a2)
Submit a response

eLetters

No eLetters have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *